Cancer-fighting immunotherapy recommended for FDA approval – Local 10
Local 10 |
Cancer-fighting immunotherapy recommended for FDA approval
Local 10 A panel of experts voted to endorse the immunotherapy drug, known as tisagenlecleucel, which treats a type of leukemia that is more common among children. Ten committee members voted in favor, and one left early without voting. None voted against. 'Living Drug' That Fights Cancer By Harnessing Immune System Clears Key Hurdle Novel cancer treatment wins endorsement of FDA advisers Landmark Novartis Immunotherapy Faces Crucial FDA Hearing Wednesday |
